Calmodulin (CaM) is one of the intracellular calcium binding proteins which regulates the functions of proteins and enzymes associated with various cellular processes (for review Klee & Newton, 1985; Cohen, 1988) . CaM has been demonstrated to regulate cyclic nucleotide metabolism (Brostrom et al., 1975) , mitosis, cell cycle progression (Rasmussen & Means, 1989) and phosphorylation of oestrogen receptor (ER) (Migliaccio et al., 1984) . It has also been reported that oestrogens influence the synthesis of CaM in the rabbit myometrium (Matsui et al., 1983) and in rat and human uteri (Yoshida et al., 1985) . Since Wei and Hickie (1981) with minor modifications. The tissue was homogenised in three volumes of Tris-HCl pH 6.8 (buffer-A), consisting of 60 mM Tris-HCI and 1 mM EGTA and the supernatant was prepared by centrifuging the homogenate at 105,000 g for 1 h at 4°C. The pellet was rehomogenised with three volumes of buffer-A and the supernatant was prepared as described above. The supernatants from the first and second centrifugation were pooled and used for the assay of CaM in the soluble fraction. To assay the CaM in the particulate fraction, the pellet was homogenised in three volumes of buffer-B, consisting of buffer-A and 2% Triton-X 100. The homogenate was left at 4°C for 2 h and stirred intermittently. The supernatant was prepared by centrifuging the homogenate at 105,000 g for 1 h at 4°C. The pellet was rehomogenised with three volumes of buffer-B and the supernatant was prepared as described above. The supernatants from these two fractions were pooled and used for the assay. CaM in the soluble and particulate fractions were assayed according to the method of Veigl et al. (1984). Briefly, samples along with 100 ng of standard CaM (Purified bovine brain CaM, Sigma Chemical Co, St. Louis, USA) was electrophoresed on 1 mm thick, 15% polyacrylamide gels and stained with silver nitrate (Morrissey, 1981) Figure 1 Correlation of ER levels with calmodulin levels in ER+ breast tumours (r = 0.77, P<0.001, n = 23).
Tumour tissue weighing 500 mg was washed, minced finely and homogenised in three volumes of 10 mM Tris buffer, pH 7.4, containing 1.5 mM EDTA, 5 mM 2-mercaptoethanol, 12 mM thioglycerol and 20% glycerol, using polytron pt-10 homogeniser in an ice bath. Cytosol was prepared by centrifuging the homogenate at 105,000 g for 1 h at 4°C and used for ER and E2 measurement. ER concentration in the tumour tissue cytosol was measured by saturation analysis. 0.2 ml of cytosol containing 1 mg protein was incubated overnight at 4°C with varying concentrations (0.2-20 nM) of [2,4,6,7-3H] Wei and Hickie (1981) with minor modifications. The tissue was homogenised in three volumes of Tris-HCl pH 6.8 (buffer-A), consisting of 60 mM Tris-HCI and 1 mM EGTA and the supernatant was prepared by centrifuging the homogenate at 105,000 g for 1 h at 4°C. The pellet was rehomogenised with three volumes of buffer-A and the supernatant was prepared as described above. The supernatants from the first and second centrifugation were pooled and used for the assay of CaM in the soluble fraction. To assay the CaM in the particulate fraction, the pellet was homogenised in three volumes of buffer-B, consisting of buffer-A and 2% Triton-X 100. The homogenate was left at 4°C for 2 h and stirred intermittently. The supernatant was prepared by centrifuging the homogenate at 105,000 g for 1 h at 4°C. The pellet was rehomogenised with three volumes of buffer-B and the supernatant was prepared as described above. The supernatants from these two fractions were pooled and used for the assay. CaM in the soluble and particulate fractions were assayed according to the method of Veigl et al. (1984) . Briefly, samples along with 100 ng of standard CaM (Purified bovine brain CaM, Sigma Chemical Co, St. Louis, USA) was electrophoresed on 1 mm thick, 15% polyacrylamide gels and stained with silver nitrate (Morrissey, 1981) Fishman et al. (1977) ; Maynard et al. (1978) , and Drafta et al. (1983) . The total CaM concentration in ER' tumours was 2.4 times higher than in the ER-tumours and the difference was statistically significant (P<0.001, Table I ). Correlation analysis was performed in ER' tumours to understand whether any relationship existed between ER and total CaM concentrations and the results showed a significant positive correlation ( Figure   1 ). In ER' and ER-tumours CaM levels were analysed in the soluble and particulate fractions to understand the distribution of CaM (Table I) . In both ER' and ER-tumours the major portion of CaM was seen in the soluble fraction representing the cytosol. The soluble and particulate CaM levels in ER' tumours were significantly higher than the corresponding fractions in ER-tumours (P<0.001).
Though ER' tumours had higher concentrations of particulate CaM than the ER-tumours the mean ratio of particulate to the soluble CaM concentrations remained the same (0.2, Table I ). The menstrual status of the breast cancer patients and the CaM levels in tumour tissues are shown in Table II . Irrespective of menopausal status CaM level and E2 levels were higher in the ER' than the ER-tumours. In conclusion, the increased E2 and CaM levels in the soluble fraction and positive correlation between ER and CaM level in ER' tumours suggest that in breast tumours CaM level is influenced by ER. This is supported by the report that administration of oestrogen to ovariectomised rabbits specifically increased the cytosol CaM concentrations in the uterus (Matsui et al., 1983) . A similar finding was reported by Yoshida et al. (1985) in rat and human uterus. 
